Sanofi India launched its new product- Toujeo® (insulin glargine injection) in India. It is once-daily, long-acting basal insulin that improves blood sugar control in people with type 1 and types 2 diabetes. Continue reading...
The top 9 drugs currently under research and developments are ranked based on their Net Present Value. These drugs are forecasted to be the future blockbuster. With $10,199 million Net Present Value, Aducanumab, the Ant-Alzheimer's investigational drug of Biogen is ranked as the topmost valued upcoming drug under development. Total Word Counts of the article: 782. Continue reading..
Novartis’ nuclear medicine subsidiary, Advanced Accelerator Applications (AAA) inked a global partnership with US-based Cancer Targeted Technology (CTT) for the development and marketing of diagnostic agent CTT1057. Continue reading....
We are kicking 2018 off with the launch of our brand new platform – Medgenera 2.0 is live!
This launch hallmark a revolution in healthcare industry media as we became the first platform to follow a 100% advertisement free reporting! Medgenera 2.0- Join the Revolution! Read the full article to know how Medgenera can benefit in your career with 'Medgenera for Student' and 'Medgenera for Professional' features.
A unicorn is a startup company with a current valuation of US$1 billion or more. In this post, Medgenera DATALABS has compiled data from 25 venture-backed private healthcare companies with post-money valuations of US $1 billion and more. Subscribe to read the full report.
MEDGENERA is Hiring! We are looking for passionate healthcare industry journalists- people who have a keen interest and an established credibility as journalist/content writer in the healthcare industry.
Healthcare in India is showing a gradual progress and there is an abundance of opportunity to create an evolving business by tackling the major challenges of the mass population. Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our observations of the current Indian market, its behavior, challenges, and opportunities.